Ligand Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.About LGND
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.
LGND Key Statistics
Stock Snapshot
With a market cap of 3.91B, Ligand Pharmaceuticals(LGND) trades at $198.43. The stock has a price-to-earnings ratio of 92.72.
During the trading session on 2025-12-18, Ligand Pharmaceuticals(LGND) shares reached a daily high of $199.39 and a low of $194.00. At a current price of $198.43, the stock is +2.3% higher than the low and still -0.5% under the high.
Trading volume for Ligand Pharmaceuticals(LGND) stock has reached 181.11K, versus its average volume of 232.1K.
Over the past 52 weeks, Ligand Pharmaceuticals(LGND) stock has traded between a high of $212.49 and a low of $93.58.
Over the past 52 weeks, Ligand Pharmaceuticals(LGND) stock has traded between a high of $212.49 and a low of $93.58.
LGND News
Ligand Pharmaceuticals (LGND) just put numbers around its 2026 outlook, projecting total revenue between $245 million and $285 million, with the bulk expected f...
New insider activity at Ligand Pharma ( (LGND) ) has taken place on December 16, 2025. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fu...
Analyst Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Ligand Pharma and keeping the price target at $231.00. Claim 50% Off TipRanks Premium a...